Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. (XLO) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 48 transactions totaling $43.2M, demonstrating a bullish sentiment with $43.2M in net insider flow. The most recent transaction on Apr 2, 2024 involved a purchase of 485,250 shares valued at $368.8K.
XLO Insider Activity Summary
Who Is Buying XLO Stock?
No significant insider buying has been recorded for XLO in the recent period.
Who Is Selling XLO Stock?
No significant insider selling has been recorded for XLO in the recent period.
Is Xilio Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for XLO is bullish with an Insider Alignment Score of 100/100 and a net flow of $43.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
XLO Frequently Asked Questions
Understanding XLO Insider Activity
Insider trading at Xilio Therapeutics, Inc. (XLO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading XLO stock, having executed 48 transactions in the past 90 days. The most active insider is Mgmt L.p. Deerfield (Executive), who has made 4 transactions totaling $12.4M.
Related Tools
Track Xilio Therapeutics, Inc. Insider Activity
Get notified when executives and directors at XLO file new Form 4 transactions